Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
For women with polycystic ovary syndrome (PCOS), a condition closely linked to insulin resistance and obesity, GLP-1-based therapies have shown some promise in improving hormonal profiles, reducing androgen levels, and restoring menstrual regularity
According to a report by Reuters, Eli Lillys drug Tirzepatide (brand name Mounjaro ) is showing exceptional results
This is linked to the GIP pathway: Insulin release that depends on glucose Keeping metabolic signals in check Having an effect on the function of pancreatic beta cells The GLP-1 pathway helps with the following: Sugar control Controlling your appetite Changes in how the stomach empties Tirzepatide works differently from other GLP-1 receptor agonists because it combines both routes into a single chemical structure
Most batteries will also list a burst C-rating
